Seattle, WA -- (SBWire) -- 11/11/2019 --A small wire mesh tube inserted in the artery with a balloon catheter is called a cardiovascular stent. In a coronary artery, accumulation of fatty acids, also known as plaque, leads to narrowing of the artery. Such narrowing reduces the blood flow to the heart that leads to chest pain. Further increase in the blockage can significantly reduce blood flow leading to cardiac arrest. A cardiovascular stent is used to reduce the chances of heart attack. The balloon catheter in the stent inflates, which expands the stent and keeps the artery open to facilitate proper blood flow to the heart. Use of angioplasty and stents prevents the re-narrowing of the arteries and aids in quicker recovery of patients compared to those who have adopted cardiovascular artery bypass surgery.
Global Cardiovascular Stents Market Dynamics
Increasing prevalence of cardiovascular disorders lead to high number of cardiovascular surgeries, which is expected to lead to high adoption of coronary or cardiovascular stents. This in turn aids in growth of the global cardiovascular stents market. Increasing geriatric population prone to cardiovascular diseases is also expected to boost growth of the market. For instance, according to the World Health Organization (WHO), the global geriatric population is expected to reach 2 billion by 2050.
Request A Sample Copy: https://www.coherentmarketinsights.com/insight/request-sample/470
However, increasing costs of coronary stents is expected to hinder growth of the market. Use of cost –containment policies and appropriateness criteria can help to reduces prices of coronary stents.
Drug eluting stents are more productive compared to other type of stents. The use of bio -absorbable polymer-coated drug eluting stents is increasing in the U.S. The Circulatory System Devices Panel of the U.S. FDA's Medical Devices Advisory Committee has approved application for the Absorb GT1 Bioresorbable Vascular Scaffold System. The DREAMS (Drug-Eluting Absorbable Metal Scaffold) device is a fully bioresorbable scaffold made from a magnesium alloy covered with a polymer and sirolimus drug coating. The stent-on –wire is also a new type of drug eluting coronary fixed wire system. Some of the recently developed coronary stents include, Tryton Side Branch Stent and PK Papyrus Covered Stent.
Global Cardiovascular Stents Market Competitive Landscape
Major players operating the cardiovascular stents market include, Getinge, Terumo, W. L. Gore & Associates, Medtronic, St. Jude Medical, Boston scientific, and Edward Lifesciences, Abbott laboratories, Johnson & Johnson, and Lepu Medical Technology.
Get PDF Brochure of This Business Report: https://www.coherentmarketinsights.com/insight/request-pdf/470
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Cardiovascular Stents Market Size, Share, SWOT Analysis Forecast to 2025